Retina

As Second Sight’s Argus II Retinal Prosthesis System nears its 100 patient milestone, we look at how the device has impacted the lives of those implanted

Many astronauts develop eye problems in space. NASA wants to know why, so they’ve established the Vision Impairment and Intracranial Pressure (VIIP) program.

Are people with certain genotypes actively harmed by AREDS supplementation, accelerating AMD?

Why are certain regions of the choroid more prone to disease than others? To answer that, you need proteomics

Imagine prescribing eye drops to treat wet AMD, or delivering genes to the retina of patients with retinitis pigmentosa. Nanotechnology can do both – and it could potentially transform ophthalmology

Popular culture has always viewed eyes as being things of beauty. But there’s more to the eye than the color of your irides.

Oral replacement therapy of the retinoid intermediate that fails to form in some types of Leber congenital amaurosis shows significant promise in an early-phase clinical trial

Might you soon take a skin cell from a patient with retinitis pigmentosa, roll it back to a pluripotent state, culture it to become retinal cells and trial gene therapy on it in vitro?

Population-level disease prophylaxis with statins has improved the lives of millions. But there has been some protest about this mass medication. Is the next battle not with disease, but with the press?

One of the most debilitating microvascular complications of diabetes is diabetic retinopathy, the most important cause of blindness among working age adults in developed countries.